NSE:LAURUSLABS - Laurus Labs Limited Stock Price & Analysis

About Laurus Labs Limited (NSE:LAURUSLABS)

(NSE:LAURUSLABS) Laurus Labs Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. It operates through Generics APIs, Generics Finished Dosage Forms (FDF), and Synthesis segments. The Generics APIs segment develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), oncology, hepatitis C, cardiovascular, antidiabetic, anti-asthmatic, gastroenterology, and ophthalmic therapeutic areas. The Generics FDF segment develops and manufactures oral solid formulations for ARVs, anti-diabetic, cardiovascular, proton pump inhibitors, and central nervous system. The Synthesis segment provides contract development and manufacturing services for pharmaceutical companies. The company also manufactures and sells specialty ingredients used in the nutraceutical, dietary supplements, and cosmeceutical products. In addition, it offers chemistry, IP development, business support, and related services to the pharmaceutical community. The company was incorporated in 2005 and is based in Hyderabad, India.

LAURUSLABS Stock Price

Statistics Highlights (NSE:LAURUSLABS)

Shares Outstanding	537.36M	Beta	1.45
Public Float	329.74M	P/E Ratio	35.89
% Short of Float	-	Dividend (Yield)	2.00 (0.01%)
Held by Insiders	38.91%	Ex-Dividend Date	May 10, 2022
Held by Institutions	19.29%	IPO Date	-

Explore More on "Statistics" Section

LAURUSLABS Financial Summary

|

	Mar 22	Mar 21	Mar 20
Revenue	INR49.36B	INR47.23B	INR27.59B
EBITDA	INR14.38B	INR15.62B	INR5.54B
Net Income	INR8.28B	INR9.84B	INR2.55B
Total Assets	INR69.68B	INR57.51B	INR37.50B
Total Cash	INR753.50M	INR484.60M	INR16.88M
Total Debt	INR	INR14.82B	INR10.79B

	Mar 22	Dec 21	Sep 21
Revenue	INR14.25B	INR10.29B	INR12.03B
EBITDA	INR3.98B	INR2.91B	INR3.46B
Net Income	INR2.27B	INR1.54B	INR2.02B
Total Assets	INR69.68B	INR	INR63.63B
Total Cash	INR753.50M	INR	INR386.70M
Total Debt	INR	INR	INR17.65B

LAURUSLABS Stock Price History

Laurus Labs Limited Annual Stock Price History

Year	Open	Close	Change
2021	INR540.10	INR651.00	20.53%
2021	INR354.80	INR540.10	52.23%
2020	INR358.00	INR354.80	-0.89%

Laurus Labs Limited Daily Stock Price History

Date	Open	High	Low	Close	Change	Volume
Jun 9, 2022	INR545.10	INR553.80	INR545.00	INR550.15	21.74%	418.18K
Jun 22, 2022	INR456.90	INR464.10	INR449.00	INR451.90	-14.29%	1.29M
Jun 13, 2022	INR540.00	INR542.80	INR525.05	INR527.25	-4.39%	926.14K

View More on "Price History" Section

(NSE:LAURUSLABS) Stock Price FAQs

What is today's stock price of Laurus Labs Limited (NSE:LAURUSLABS)?

The current stock price of Laurus Labs Limited (NSE:LAURUSLABS) is INR651.00.
Today LAURUSLABS stock price opened at INR636.70 after previous close of INR634.40.
During the day, Laurus Labs Limited stock quote has varied from a low of INR628.20 to a high of INR653.40.

What is Laurus Labs Limited's 52-week change?

LAURUSLABS 52-week high stock quote is INR722.58, which is 11.00% above the current share price.
The Laurus Labs Limited (NSE:LAURUSLABS) 52-week low stock price is INR440.00, which is 32.40% below the current share price.
Laurus Labs Limited share price volatility (52-week beta) is 1.45.

Laurus Labs Limited (NSE:LAURUSLABS) FAQ

How Much is Laurus labs limited Worth?

Laurus labs limited's worth today based on market capitalisation is INR296.03B

How much dividend does Laurus labs limited Pay?

The current annualized dividend payout for LAURUSLABS stock is INR4.80, the dividend yield is 0.83% and the payout ratio is 10.42%.
View More Details on Laurus labs limited's "Dividend" Section

What is Laurus labs limited’s Price to Earning (PE) ratio?

Laurus labs limited has a Price to Earning (P/E) ratio of 35.89. LAURUSLABS stock also has a Price to Sales (P/S) ratio of 6.00.

What is the Laurus labs limited's ticker?

Laurus labs limited trades on the NSE stock market in India under the ticker symbol "LAURUSLABS". Laurus labs limited’s stock symbol can also be displayed as "NSE:LAURUSLABS".

Who are the owners of Laurus labs limited?

Laurus labs limited (NSE:LAURUSLABS) is owned by 19.29% institutional shareholders and by 38.91% insiders. The rest is owned by the public.
Explore More Details on Laurus labs limited's “Ownership” Section

Who are the key executives of Laurus labs limited (LAURUSLABS)?

Laurus labs limited's key executive team includes the following managers:

Dr. Satyanarayana Chava M.Sc., Ph.D., CEO & Whole Time Director (1961)
Mr. Vantaram Venkata Ravi Kumar F.C.M.A., DIS, Dip in Mgmt., CFO & Whole-Time Director (1965)
Mr. Narasimha Rao Chava, Sr. VP of HR (1968)
Mr. Srinivasa Rao Suryadevara M.Sc., B.Sc, Sr. VP of Manufacturing (1963)
Dr. Vaidyanathan Narayanaswamy Iyer, Sr. VP (1963)
Mr. Chagarlamudi Sita Ramaiah, Sr. VP of Fin. (1973)
Mr. Dammalapati Venkata Lakshmi Narasimha Rao, Sr. VP of Synthesis (1969)
Mr. Krishna Chaitanya Chava, Exec. VP and Head of Synthesis & Ingredients (1990)
Mr. Vivek Kumar, Sr. Gen. Mang. of Investor Relations (NA)
Mr. Gogireddy Venkateswar Reddy, Asst. VP of Legal & Secretarial, Compliance Officer & Company Sec. (NA)

What is Laurus labs limited’s Sector & Industry Classification?

Laurus labs limited (NSE:LAURUSLABS) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.

How many employees work for Laurus labs limited?

Currently the number of employees working for Laurus labs limited is 0.

Where are Laurus labs limited's Headquarters?

Laurus labs limited (NSE:LAURUSLABS) is headquartered in India.

What are Laurus labs limited's Address and Phone Number?

Laurus labs limited’s mailing address is Serene Chambers, Hyderabad, India, 500034.
The company’s phone number is 91 40 3980 4333.

What is the official website for Laurus labs limited?

Laurus labs limited’s official website is http://www.lauruslabs.com

Laurus Labs Limited Stock (NSE:LAURUSLABS)